You are here: Industry Insights > CDMO

News List

Metrics Contract Services Appoints VP of Business Development contractpharma
February 03, 2021
Metrics Contract Services, a full-service contract development and manufacturing organization (CDMO) in novel oral solid dose products, has appointed Britton Jimenez as vice president of business development.
CDMO WuXi STA Expands Footprint in Europe contractpharma
February 03, 2021
WuXi STA, a subsidiary of WuXi AppTec, has agreed to purchase Bristol Myers Squibb’s manufacturing facility in Couvet, Switzerland.
CDMO Northway Biotech Expands in U.S. contractpharma
January 22, 2021
Northway Biotech, a biopharmaceutical contract development and manufacturing organization (CDMO), established in 2004, with an EMA and FDA-compliant, state-of-the-art, cGMP manufacturing site in Europe, has opened its new 30,000-square-foot process ...
NovaQuest Private Equity Acquires CoreRx contractpharma
January 20, 2021
NovaQuest Private Equity has acquired CoreRx, a global contract development and manufacturing organization (CDMO).
Fujifilm, CABIM Get $76M Funding for Mfg. and Innovation Center contractpharma
January 15, 2021
FUJIFILM Corp. and the Center for Advanced Biological Innovation and Manufacturing (CABIM), have secured $76 million in financing and signed a lease for a 40,000 square-foot site in Watertown, MA.
Alcami Expands Oral Solid Capabilities contractpharma
January 12, 2021
Alcami, a U.S.-based contract development and manufacturing organization (CDMO), announced an additional $2 million investment to expand its oral solid development and manufacturing capabilities in Wilmington, NC.
Fujifilm to Invest $40M in New Facility contractpharma
January 06, 2021
Fujifilm Corporation has announced an investment of approximately $40 million in Fujifilm Diosynth Biotechnologies, a contract development and manufacturing organization (CDMO) for biologics, viral vaccines and viral vectors, to establish a new ...
Genezen Laboratories Receives Growth Equity Investment contractpharma
January 06, 2021
Genezen Laboratories Inc. has received a majority investment from Ampersand Capital Partners, a private equity firm specializing in growth equity investments in the healthcare sector.
CHA Biotech Launches Global CDMO Biz contractpharma
December 17, 2020
South Korea-based CHA Biotech has launched Matica Biotechnology, a contract development and manufacturing organization (CDMO) specializing in the clinical and commercial production of cell and gene therapies.
CDMO Cognate BioServices Teams Up with L7 Informatics contractpharma
December 17, 2020
L7 Informatics has partnered with Cognate BioServices, a commercial-ready contract development and manufacturing organization (CDMO) in the cell and gene therapy industry, to deploy L7|ESP (Enterprise Science Platform) and implement an integrated ...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 28 29 Next page